Research

Meet our Faculty

James Ferri, Ph.D.

Research Specialties:

  • Interfacial phenomena
  • Stability in disperse systems
  • Process intensification
  • Advanced manufacturing

Stephen Fong, Ph.D.
Fong Lab

Research Specialties:

  • Metabolic engineering
  • Systems biology
  • Synthetic biology
  • Urban sustainability

Ram Gupta, Ph.D.

Research Specialties:

  • Batteries
  • Biomaterials
  • Energy
  • Supercritical fluids
  • Sustainable engineering

Frank Gupton, Ph.D.
Gupton Lab

Research Specialties:

  • Cross-coupling catalysis
  • Flow chemistry/continual chemical processing
  • Organic synthesis in pharmaceuticals

Mo Jiang, Ph.D.

Research Specialties:

  • Continuous pharmaceutical manufacturing
  • Protein crystallization
  • Process design & control

Nastassja Lewinski, Ph.D.
Lewinski Lab

Research Specialties:

  • Biological effects of nanoparticles
  • Advanced in vitro exposure systems
  • Nanomedicines & naninformatics

Michael Peters, Ph.D.
Peters Lab

Research Specialties:

  • Protein engineering viral therapeutics
  • Cancer therapeutics Alzheimer's
  • Disease research

Tom Roper, Ph.D.
Roper Lab

Research Specialties:

  • Metabolic engineering
  • Systems biology
  • Synthetic biology
  • Urban sustainability

Christina Tang, Ph.D.
Tang Lab

Research Specialties:

  • Multifunctional textiles & polymer composites
  • Self-assembly of metal-polymer hybrid nanoparticles

Xuejun Wen, Ph.D.

Research Specialties:

  • Biomaterials
  • Drug delivery
  • Medical devices
  • 3D printing
  • Nanotechnology

Vamsi Yadavalli, Ph.D.
Yadavalli Lab

Research Specialties:

  • Biosensors
  • Flexible bioelectronics
  • Sustainable materials
  • Nanoscience

 

M4ALL-P Partnership

VCU Engineering’s Medicines for All Institute partners with industry to secure the domestic pharmaceutical supply chain

To prevent domestic shortages of critical medications, the Medicines for All Institute, based in the Virginia Commonwealth University College of Engineering, has joined forces with pharmaceutical industry leaders to bring manufacturing of vulnerable pharmaceuticals and their ingredients back to the United States.